Endo Health Solutions said today it is acquiring Canadian-based specialty pharma company Paladin Labs for roughly $1.6 billion, in a stock and cash deal that expands the buyer’s global presence, ...

THIS MEDIA RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Paladin Labs Inc. (PLB.TO) ("Paladin") today announced that it has reached a ...

Endo Health Solutions, a US-based specialty healthcare company, has reached a definitive agreement to acquire Paladin Labs Inc., a leading Canada-based specialty pharmaceutical company, in a stock and ...

DUBLIN, July 15, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into agreements with Quoin Pharmaceuticals Inc.

Accretive transaction accelerates Endo's transformation into a leading specialty healthcare company Creates a compelling financial and operational platform for future growth Establishes Endo's global ...

View post: 25-year-old women’s fashion chain closes stores, no bankruptcy Terms of the deal call for Malvern, Pa.-based Endo to pay C$77 for each Paladin share, a premium of 20% to the target’s $63.91 ...

Endo Health Solutions Inc. ENDP agreed to buy Canadian specialty-pharmaceutical company Paladin Labs Inc. (PLDLF, PLB.T) for about $1.6 billion, allowing Endo to continue its transition into a ...

DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with Radius Health, Inc.

(Reuters) - Endo International Plc has discussed a sale of Paladin Labs Inc, its Montreal-based specialty pharmaceutical subsidiary, to Canadian drug maker Knight Therapeutics Inc , people familiar ...

MALVERN, Pa. (AP) -- Endo Health will spend about $1.5 billion to buy the Canadian specialty drug maker Paladin Labs, and both will then be folded into a newly-formed Irish holding company. Endo also ...

Endo International plc (Nasdaq: ENDP; TSX: ENL), formerly Endo Health Solutions Inc., announced today that it has completed the acquisition of Paladin Labs Inc. in a stock and cash transaction ...

The product is under investigation for the treatment of Netherton syndrome, a rare disease DUBLIN, July 15, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its ...